The PLCO analysis used the same metabolomic assay as the ATBC analyses, although on non-fasting rather than fasting serum samples, but in contrast to any of the other studies, participants were all screened for prostate cancer using an annual PSA test and digital rectal examination [11]. This evidence concerns the gene KLK3 and Familial prostate cancer.